当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析 - 现金流量表

联环药业

(600513)

  

流通市值:62.14亿  总市值:62.14亿
流通股本:2.85亿   总股本:2.85亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,037,034,996.331,276,964,705.54644,962,797.462,309,204,334.22
  收到的税费返还---145,435.07
  收到其他与经营活动有关的现金44,110,866.320,038,191.4911,910,082.8532,528,428.88
  经营活动现金流入小计2,081,145,862.631,297,002,897.03656,872,880.312,341,878,198.17
  购买商品、接受劳务支付的现金1,263,182,059.53748,693,152.21372,094,979.841,190,180,455.6
  支付给职工以及为职工支付的现金170,132,783.72107,949,942.5157,814,437.85178,729,418.35
  支付的各项税费158,533,205.81114,683,028.5970,775,000.42190,813,734.65
  支付其他与经营活动有关的现金662,178,968.82483,486,386.72209,284,326.13771,388,817.41
  经营活动现金流出小计2,254,027,017.881,454,812,510.03709,968,744.242,331,112,426.01
  经营活动产生的现金流量净额-172,881,155.25-157,809,613-53,095,863.9310,765,772.16
二、投资活动产生的现金流量:
  收回投资收到的现金---22,000,000
  取得投资收益收到的现金---6,552.78
  处置固定资产、无形资产和其他长期资产收回的现金净额16,4686,4682,8686,194.69
  投资活动现金流入小计16,4686,4682,86822,012,747.47
  购建固定资产、无形资产和其他长期资产支付的现金167,767,322.53132,788,855.1781,421,409.17184,845,345.89
  投资支付的现金125,009,52873,495,298.11-22,000,000
  取得子公司及其他营业单位支付的现金--112,833,640.92-
  投资活动现金流出小计292,776,850.53206,284,153.28194,255,050.09206,845,345.89
  投资活动产生的现金流量净额-292,760,382.53-206,277,685.28-194,252,182.09-184,832,598.42
三、筹资活动产生的现金流量:
  取得借款收到的现金1,223,929,218.01971,181,555.46519,387,620.14847,979,092.69
  收到其他与筹资活动有关的现金82,489,00015,000,00015,000,0005,000,000
  筹资活动现金流入小计1,306,418,218.01986,181,555.46534,387,620.14852,979,092.69
  偿还债务支付的现金651,569,847.75466,456,514.42224,597,282.74673,485,809.95
  分配股利、利润或偿付利息支付的现金45,126,236.0236,205,754.027,202,674.954,335,291.39
  其中:子公司支付给少数股东的股利、利润-5,365,000-3,770,000
  支付其他与筹资活动有关的现金79,828,022.7258,167,639.01-15,216,027.33
  筹资活动现金流出小计776,524,106.49560,829,907.45231,799,957.64743,037,128.67
  筹资活动产生的现金流量净额529,894,111.52425,351,648.01302,587,662.5109,941,964.02
四、汇率变动对现金及现金等价物的影响160,194.55221,602.02199,397.61628,724.91
五、现金及现金等价物净增加额64,412,768.2961,485,951.7555,439,014.09-63,496,137.33
  加:期初现金及现金等价物余额186,693,885.24186,693,885.24186,693,885.24250,190,022.57
  期末现金及现金等价物余额251,106,653.53248,179,836.99242,132,899.33186,693,885.24
补充资料:
  净利润--32,357,597.04-106,414,745.34
  资产减值准备-927,206.48-5,211,934.12
  固定资产和投资性房地产折旧-31,302,262.03-50,341,329.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-31,302,262.03-50,341,329.05
  无形资产摊销-10,096,922.66-9,434,676.23
  长期待摊费用摊销-934,054.43-1,421,895.07
  处置固定资产、无形资产和其他长期资产的损失--5,723.89--35,029,139.47
  固定资产报废损失-21,815.28-112,393.52
  财务费用-15,270,367.37-24,322,402.84
  投资损失-1,491,479.24-9,119,037.86
  递延所得税-717,074.63-1,530,567.13
  其中:递延所得税资产减少-1,076,819.49-1,208,825.2
    递延所得税负债增加--359,744.86-321,741.93
  存货的减少--20,343,726.1--134,268,447.07
  经营性应收项目的减少--164,636,393.33--60,135,503.65
  经营性应付项目的增加--4,514,868.96-23,342,889.05
  不涉及现金收支的投资和筹资活动金额其他项目---3,893,364.69
  现金的期末余额-248,179,836.99-186,693,885.24
  减:现金的期初余额-186,693,885.24-250,190,022.57
  现金及现金等价物的净增加额-61,485,951.75--63,496,137.33
公告日期2025-10-252025-08-272025-04-302025-04-18
审计意见(境内)标准无保留意见
TOP↑